Calpain Therapeutics

Based in Adelaide, Australia, Calpain Therapeutics Pty Ltd is a privately-funded biotechnology venture dedicated to the development of proprietary candidate drug compounds having the potential to impact the progression of major ophthalmic diseases and enhance the quality of patients' lives.


Many therapies available today treat only the symptoms of the diseases, and have little-to-no effect on the molecular-level cause of eye disease progression. Calpain Therapeutics seeks to redefine ophthalmology by developing new drugs that treat the root cause of the vision loss.